Navigation Links
SPC2996 in Medical Technology

Santaris Pharma presents positive preclinical data on SPC2996 at the American Association for Cancer Research

Bcl-2 Antagonist shown to be therapeutically effective in a mouse model of Chronic Lymphocytic Leukaemia COPENHAGEN, 18 April 2007 - Santaris Pharma, the Danish biopharmaceutical company developing RNAi drugs, yesterday presented encouraging data at the American Association for Cancer Research A...

Santaris Pharma Presents Positive Clinical Data on SPC2996 in Chronic Lymphocytic Leukaemia

First RNA Antagonist Medicine to Be Tested in Patients Reduces Severity of Adult Leukaemia Copenhagen, 6th June 2007 - Santaris Pharma, the Danish biopharmaceutical company, announced today that SPC2996, the Company's new RNA Antagonist of Bcl-2, has shown early evidence of efficacy in an initia...
SPC2996 in Biological Technology

Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009

... own development activities within metabolic disorders and infectious diseases, it has been decided to divest the activities within the development of spc2996 targeting CLL. This process is ongoing. EZN3042-Survivin In February 2009 Santaris Pharma's collaboration partner Enzon Pharmaceuticals ...
SPC2996 in other areas

News - FDA Approves IND for SPC2996 in Chronic Lymphocytic Leukaemia

SPC2996 is the first of a new class of LNA-based investigational drugs known as ... SPC2996 acts by inhibiting the synthesis of Bcl-2, a key intracellular protein ...

Definition of oligonucleotide SPC2996 - National Cancer Institute Drug ...

The search textbox has an autosuggest feature. ... Oligonucleotide SPC2996 binds to and inactivates Bcl-2 mRNA, thereby inhibiting ...

SPC2996 in Chronic Lymphocytic Leukaemia - Full Text View ...

SPC2996 in Chronic Lymphocytic Leukaemia. This study is ongoing, but not recruiting participants. ... Dose Escalating, Phase I/II Study of SPC2996,an LNA ...

Investigational New Drug Application Approved for SPC2996 for Treatment ...

SPC2996 is an RNA antagonist that has been designed to reduce Bcl-2 protein ... II study is currently ongoing to evaluate SPC2996 in relapsed or refractory CLL. ...

Santaris Pharma presents positive preclinical data on SPC2996 at the ...

SPC2996 was tested for anti-leukaemic activity over two weeks in this model ... Therapy with SPC2996 resulted in a 54% reduction (p=0.043) in the number of CLL ...

Report and Accounts 2005

Investigational New Drug application for SPC2996, which enabled ... These compounds, like SPC2996, have been ... SPC2996, under Good Manufacturing Practice ...
Other Tags
(Date:10/1/2014)... protein beta-amyloid is strongly associated with Alzheimer,s disease; however, ... peptide is the causal agent of the onset and ... confirmation is that beta-amyloid is not harmful when found ... when it self-assembles to form the so-called amyloid fibrils ... beta-amyloid alone, but with multiple ones because each aggregate ...
(Date:10/1/2014)... new research study published today in the Journal ... patients older than 50 years with moderate or severe ... , Researchers from the University of Melbourne randomly assigned ... pain to no acupuncture or sham or pretend laser ... with participants and acupuncturists blinded to laser and sham ...
(Date:10/1/2014)... Physical Sciences Research Council (EPSRC) will focus on ... systems which run, for example, manufacturing plants, power ... , The research will help understand and ... systems behind our critical national infrastructure. , ... (RITICS), based at Imperial College London, is co-ordinating ...
(Date:10/1/2014)... BOSTON (October 1, 2014) Despite a policy ... with developmental disabilities, this vulnerable population continues to ... of The Journal of the American Dental ... Medicine and Tufts University School of Dental Medicine ... factors influencing at-home oral care provided by caregivers ...
(Date:10/1/2014)... 2014 Familylifeinsurancequotes.org has released a ... for senior citizens. , Senior citizens can qualify ... sell coverage to seniors who are over 50 years ... without taking a medical examination. , Term life insurance ... senior clients can qualify. Having life insurance during retirement ...
Breaking Medicine News(10 mins):Health News:Laying siege to beta-amyloid, the key protein in Alzheimer's disease 2Health News:Study finds acupuncture does not improve chronic knee pain 2Health News:£2.5 million to recognize and reduce cyber-attack threats to critical infrastructure 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 3Health News:Affordable Term Life Insurance - Senior Citizens Can Qualify for Coverage! 2
(Date:9/30/2014)... comes to using marijuana, new research, involving mice and ... Journal of Leukocyte Biology , suggests that ... you should. That,s because a team of Italian scientists ... serious long-term damage to the immune system. This damage ... such as multiple sclerosis, inflammatory bowel disease and rheumatoid ...
(Date:9/30/2014)... release is available in German . ... their behavioural response to risky situations such as exposure ... Ornithology now found in a long-term study on different ... both metabolic rate and ambient temperature. High metabolic rates ... as in these scenarios birds were more likely to ...
(Date:9/30/2014)... -- Winners of The Economist,s prestigious Innovation awards 2014 ... place at the JW Marriott Hong Kong on Friday, October 10 ... their experiences and the lessons those hold for others. The awards, ... the past decade, will be presented at a ceremony in ... will be the first time the ceremony has come to ...
Breaking Biology News(10 mins):Adolescent exposure to thc may cause immune systems to go up in smoke 2Risky metabolism 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 3Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 4Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 5Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 6Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 7
Other Contents